Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: A randomized controlled trial of text message reminders

AIDS

Volumn 25, Issue 6, 2011, Pages 825-834

  Pop Eleches, Cristian ^a   Thirumurthy, Harsha ^b,c   Habyarimana, James P ^c   Zivin, Joshua G ^d   Goldstein, Markus P ^e   De Walque, Damien ^e   MacKeen, Leslie ^f   Haberer, Jessica ^g   Kimaiyo, Sylvester ^h   Sidle, John ^h,i   Ngare, Duncan ^h   Bangsberg, David R ^j,k  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b IL   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WORLD BANK   (United States)

^f UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h MOI UNIVERSITY   (Kenya)

ⁱ INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^k MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

more..

Author keywords

adherence; antiretroviral therapy; HIV AIDS; mobile phones; randomized controlled trial; sub Saharan Africa; text message reminders

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

ADULT; AFRICA; ARTICLE; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOBILE PHONE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; WIRELESS COMMUNICATION;

ADULT; ANTI-RETROVIRAL AGENTS; CELLULAR PHONE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; KENYA; MALE; PATIENT COMPLIANCE; REMINDER SYSTEMS; RURAL HEALTH;

EID: 79953755714     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834380c1     Document Type: Article

References (44)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-860. (Pubitemid 28135961)
2. Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 2002; 16:1051-1058. (Pubitemid 34499429)
3. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr 2004; 35:261-268. (Pubitemid 38280651)
4. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001; 15:1181-1183. (Pubitemid 32549871)
5. Hogg R, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, Montaner JS. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 2002; 16:1051-1058. (Pubitemid 34499429)
6. Bartlett JA, Shao JF. Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. Lancet Infect Dis 2009; 9:637-649.
7. Harries AD, Nyangulu DS, Hargreaves NJ, Kaluwa O, Salaniponi FM. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001; 358:410-414. (Pubitemid 32739108)
8. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS 2005; 19:1243-1249. (Pubitemid 41224892)
9. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006; 296:679-690. (Pubitemid 44200639)
10. Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 2003; 17:1369-1375. (Pubitemid 36819851)
11. Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr 2009; 51:65-71.
12. Unge C, Sodergard B, Ekstrom AM, Carter J, Waweru M, Ilako F, et al. Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya. J Acquir Immune Defic Syndr 2009; 50:397-402.
13. Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, Musoke P, Bangsberg DR. Longitudinal antiretroviral adherence in HIVR Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: role of depression in declining adherence over time. AIDS Behav 2009; 13 (Suppl 1):82-91.
14. Mannheimer SB, Matts J, Telzak E, Chesney M, Child C, Wu AW, Friedland G, Terry Beirn Community Programs for Clinical Research on AIDS. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care 2005; 17:10-22.
15. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr 2006; 43 (Suppl 1):S23-S35. (Pubitemid 44885639)
16. International Telecommunications Union. Measuring the information society: the ICT development index. Geneva, Switzerland: International Telecommunication Union; 2009.
17. Fjeldsoe BS, Marshall AL, Miller YD. Behavior change interventions delivered by mobile telephone short-message service. Am J Prev Med 2009; 36:165-173.
18. Chang LW, Kagaayi J, Nakigozi G, Packer AH, Serwadda D, Quinn TC, et al. Responding to the human resource crisis: peer health workers, mobile phones, and HIV care in Rakai, Uganda. AIDS Patient Care STDS 2008; 22:173-174. (Pubitemid 351380162)
19. Lester R, Karanja S. Mobile phones: exceptional tools for HIV/AIDS, health, and crisis management. Lancet Infect Dis 2008; 8:738-739.
20. Andrade AS, McGruder HF, Wu AW, Celano SA, Skolasky RL Jr, Selnes OA, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis 2005; 41:875-882. (Pubitemid 41266757)
21. Mannheimer SB, Morse E, Matts JP, Andrews L, Child C, Schmetter B, Friedland GH, Terry Beirn Community Programs for Clinical Research on AIDS. Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial. J Acquir Immune Defic Syndr 2006; 43 (Suppl 1):S41-47.
22. Wise J, Operario D. Use of electronic reminder devices to improve adherence to antiretroviral therapy: a systematic review. AIDS Patient Care STDS 2008; 22:495-504.
23. Frick PA, Lavreys L, Mandaliya K, Kreiss JK. Impact of an alarm device on medication compliance in women in Mombasa, Kenya. Int J STD AIDS 2001; 12:329-333. (Pubitemid 32453140)
24. Castro A. Adherence to antiretroviral therapy: merging the clinical and social course of AIDS. PLoS Med 2005; 2: e338.
25. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006; 3:e438.
26. Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, Bangsberg DR. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS One 2008; 3: e2783.
27. Wools-Kaloustian K, Kimaiyo S, Diero L, Siika A, Sidle J, Yiannoutsos CT, et al. Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 2006; 20:41-48. (Pubitemid 41818113)
28. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 2007; 4:e298.
29. Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007; 21:965-971. (Pubitemid 46684328)
30. Remien RH, Stirratt MJ, Dolezal C, Dognin JS, Wagner GJ, Carballo-Dieguez A, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS 2005; 19:807-814. (Pubitemid 40834751)
31. Liu H, Miller LG, Hays RD, Golin CE, Wu T, Wenger NS, Kaplan AH. Repeated measures longitudinal analyses of HIV virologic response as a function of percentage adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr 2006; 41:315-322.
32. Medicins Sans Frontiers. Untangling the web of antiretroviral therapy price reductions. Geneva, Switzerland: Medicins Sans Frontiers; 2010.
33. Safren SA, Hendriksen ES, Desousa N, Boswell SL, Mayer KH. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care 2003; 15:787-793. (Pubitemid 37494568)
34. Ostrop NJ, Gill MJ. Antiretroviral medication adherence and persistence with respect to adherence tool usage. AIDS Patient Care STDS 2000; 14:351-358. (Pubitemid 30480377)
35. Fisher JD, Cornman DH, Norton WE, Fisher WA. Involving behavioral scientists, healthcare providers, and HIV-infected patients as collaborators in theory-based HIV prevention and antiretroviral adherence interventions. J Acquir Immune Defic Syndr 2006; 43 (Suppl 1):S10-S17. (Pubitemid 44885637)
36. Elder JP, Ayala GX, Harris S. Theories and intervention approaches to health-behavior change in primary care. Am J Prev Med 1999; 17:275-284. (Pubitemid 29505474)
37. Shet A, Arumugam K, Rodrigues R, Rajagopalan N, Shubha K, Raj T, et al. Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in south India. AIDS Behav 2010; 4:716-720.
38. Bangsberg DR, Deeks SG. Spending more to save more: interventions to promote adherence. Ann Intern Med 2010; 152:54-56; W-13.
39. Oyugi JH, Byakika-Tusiime J, Charlebois ED, Kityo C, Mugerwa R, Mugyenyi P, Bangsberg DR. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004; 36:1100-1102. (Pubitemid 38989377)
40. Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, et al. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Eur J Clin Pharmacol 2007; 63:1115-1121. (Pubitemid 350112758)
41. Bell DJ, Kapitao Y, Sikwese R, van Oosterhout JJ, Lalloo DG. Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr 2007; 45:560-563. (Pubitemid 47294929)
42. Deschamps AE, Graeve VD, van Wijngaerden E, De Saar V, Vandamme AM, van Vaerenbergh K, et al. Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using medication event monitoring system. AIDS Patient Care STDS 2004; 18:644-657. (Pubitemid 39579158)
43. The Economist. Beyond voice: new uses for mobile phones could launch another wave of development. The Economist Newspaper Limited; 24 September 2009.
44. Kaplan WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Global Health 2006; 2:9.